ES2207274T3 - Composiciones comprimidas que contienen goma de xantano clarificada. - Google Patents

Composiciones comprimidas que contienen goma de xantano clarificada.

Info

Publication number
ES2207274T3
ES2207274T3 ES99941487T ES99941487T ES2207274T3 ES 2207274 T3 ES2207274 T3 ES 2207274T3 ES 99941487 T ES99941487 T ES 99941487T ES 99941487 T ES99941487 T ES 99941487T ES 2207274 T3 ES2207274 T3 ES 2207274T3
Authority
ES
Spain
Prior art keywords
xanthan gum
sustained release
active ingredient
ibuprofen
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99941487T
Other languages
English (en)
Spanish (es)
Inventor
Maureen The Boots Company Plc Dixey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Application granted granted Critical
Publication of ES2207274T3 publication Critical patent/ES2207274T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES99941487T 1998-08-01 1999-07-28 Composiciones comprimidas que contienen goma de xantano clarificada. Expired - Lifetime ES2207274T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9816723.2A GB9816723D0 (en) 1998-08-01 1998-08-01 Therapeutic agents
GB9816723 1998-08-01

Publications (1)

Publication Number Publication Date
ES2207274T3 true ES2207274T3 (es) 2004-05-16

Family

ID=10836508

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99941487T Expired - Lifetime ES2207274T3 (es) 1998-08-01 1999-07-28 Composiciones comprimidas que contienen goma de xantano clarificada.

Country Status (16)

Country Link
EP (1) EP1100471B1 (enExample)
JP (1) JP2002522376A (enExample)
CN (1) CN1160060C (enExample)
AR (1) AR019981A1 (enExample)
AT (1) ATE249815T1 (enExample)
AU (1) AU744483B2 (enExample)
CA (1) CA2339190C (enExample)
DE (1) DE69911427T2 (enExample)
DK (1) DK1100471T3 (enExample)
ES (1) ES2207274T3 (enExample)
GB (1) GB9816723D0 (enExample)
MX (1) MXPA01000992A (enExample)
NZ (1) NZ509593A (enExample)
PT (1) PT1100471E (enExample)
WO (1) WO2000007569A1 (enExample)
ZA (1) ZA200100828B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030034171A (ko) 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
WO2003026743A2 (en) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CN117752805B (zh) * 2023-12-25 2024-12-24 山东聊城阿华制药股份有限公司 一种药用辅料及其制备方法
KR102881485B1 (ko) * 2024-03-22 2025-11-05 (주) 팜젠사이언스 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135979A (en) * 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
EP0399774A1 (en) * 1989-05-24 1990-11-28 Merck & Co. Inc. Composition and method for rheology controlled printing of fabric and carpet

Also Published As

Publication number Publication date
CN1354653A (zh) 2002-06-19
WO2000007569A1 (en) 2000-02-17
CN1160060C (zh) 2004-08-04
EP1100471B1 (en) 2003-09-17
NZ509593A (en) 2002-12-20
CA2339190C (en) 2008-11-18
ATE249815T1 (de) 2003-10-15
AU744483B2 (en) 2002-02-28
ZA200100828B (en) 2001-10-22
EP1100471A1 (en) 2001-05-23
JP2002522376A (ja) 2002-07-23
PT1100471E (pt) 2003-12-31
CA2339190A1 (en) 2000-02-17
DE69911427T2 (de) 2004-07-01
DE69911427D1 (de) 2003-10-23
MXPA01000992A (es) 2002-06-04
AU5508799A (en) 2000-02-28
DK1100471T3 (da) 2004-01-12
AR019981A1 (es) 2002-03-27
GB9816723D0 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
US11975097B2 (en) Fast dissolving solid dosage form
ES2223669T3 (es) Forma oral de dosificacion "una vez al dia" de metoprolol.
FI93608B (fi) Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi
ES2322405T3 (es) Matriz de liberacion controlada para farmacos insolubles en dosis elevadas.
ES2301537T3 (es) Comprimidos y formulacion de guaifenesina de liberacion sostenida.
Sanjana et al. Preparation and evaluation of in-situ gels containing hydrocortisone for the treatment of aphthous ulcer
SE453797B (sv) Terapeutisk, solid enhetsdoseringsform med forlengt utlosningsmonster vars berarmaterial innehaller hydroxypropylmetylcellulosa med hog molekyler vikt
WO2010057036A2 (en) Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
TW200803831A (en) Solid pharmaceutical compositions containing pregabalin
ES2310686T3 (es) Composiciones de liberacion controlada.
JP2009544706A (ja) 高用量の経口的に溶解可能／分解可能な凍結乾燥剤形
Kumar et al. Fast dissolving tablets: waterless patient compliance dosage forms
IL298732A (en) Treatment methods for major depressive disorder and treatment-resistant depression
JPH05502894A (ja) 放出制御性製剤及び方法
ES2325599T3 (es) Sistema de enmascaramiento del sabor para farmacos no plastificantes.
AU611740B2 (en) Pharmaceutical composition and process for its preparation
EP1100471B1 (en) Compressed compositions comprising clarified xanthan gum
US20180318228A1 (en) Method for a slow release of drugs from orally dissolving capsules
CN104434860A (zh) 包合工艺制备的盐酸氨溴索渗透泵型药物组合物
PRAKASH et al. A Systematic Review of the Application of Natural Polymers in the Formulation of ORO-Dispersible Tablet
JPH11116465A (ja) 迅速溶解性製剤およびその製造法
CN1172429A (zh) 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
US20030138486A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents
JPS615027A (ja) 徐放性固形製剤
AHMED GASTRO RETENTIVE SYSTEMS FOR EFFECTIVE DELIVERY OF CAPTOPRIL AND DILTIAZEM